Nagla Abdel Karim
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors (NCT03023319) | Nagla Abdel Karim | 2019-12-10 |
Track Nagla Abdel Karim automatically
Every clearance here is in the API, with alerts when new ones post.